Advertisement
Singapore markets closed
  • Straits Times Index

    3,313.48
    +8.49 (+0.26%)
     
  • Nikkei

    38,787.38
    -132.88 (-0.34%)
     
  • Hang Seng

    19,553.61
    +177.08 (+0.91%)
     
  • FTSE 100

    8,420.26
    -18.39 (-0.22%)
     
  • Bitcoin USD

    66,962.24
    -107.89 (-0.16%)
     
  • CMC Crypto 200

    1,368.72
    -5.13 (-0.37%)
     
  • S&P 500

    5,303.27
    +6.17 (+0.12%)
     
  • Dow

    40,003.59
    +134.21 (+0.34%)
     
  • Nasdaq

    16,685.97
    -12.35 (-0.07%)
     
  • Gold

    2,419.80
    +34.30 (+1.44%)
     
  • Crude Oil

    80.00
    +0.77 (+0.97%)
     
  • 10-Yr Bond

    4.4200
    +0.0430 (+0.98%)
     
  • FTSE Bursa Malaysia

    1,616.62
    +5.51 (+0.34%)
     
  • Jakarta Composite Index

    7,317.24
    +70.54 (+0.97%)
     
  • PSE Index

    6,618.69
    -9.51 (-0.14%)
     

Compliance staff salaries becoming one of the highest in Singapore pharma

Compliance staff receiving pay increases as other positions stagnate.

In a new report, international consulting and staffing firm Berkley notes that compliance staff now some of the most highly paid within the Pharmaceutical sector.

46% of pharma companies surveyed say they have increased compliance staff.

"With pay increases for senior regulatory staff having increased by an average of 9% per year over the last three years – compliance is one area of the pharmaceutical sector to have bucked stagnating wage growth created by cost cutting," said Berkley in a release accompanying its survey report.

Berkley says that some senior compliance staff are now earning as much as £200,000 in basic pay, with demand for their expertise and climbing pay awards driven by:

ADVERTISEMENT
  • Regulatory clampdown: US regulators are taking a tougher stance towards drugs companies, with a particular emphasis on post-market drug safety, in response to criticism that they were too cosy to the drugs industry.

  • Emerging markets: Drugs businesses are accelerating expansion into emerging markets and need to overcome regulatory hurdles rapidly to coordinate global product launches.

  • Biotech or biologics drugs: Production focus is shifting towards growth areas such as biotech or biologics drugs, which carry greater challenges for compliance staff.

In Singapore, Regulatory Leads earned an average of S$140,000 in 2012, a 40% increase from 2009 salary levels. QA Lead Auditors now average $95,000, a 19% increase from 2009. Meanwhile, Compliance Specialists now average S$90,000, up 38% from 2009.

Berkley says that salaries in other positions at pharmaceutical businesses, such as R&D/drug discovery have remained static over the same period as companies have looked to cut costs.



More From Singapore Business Review